HomeSMMT • NASDAQ
add
Summit Therapeutics Inc
Nakaraang pagsara
$15.38
Sakop ng taon
$13.83 - $36.91
Market cap
11.93B USD
Average na Volume
2.54M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 224.92M | 242.80% |
Net na kita | -219.17M | -258.11% |
Net profit margin | — | — |
Kita sa bawat share | — | — |
EBITDA | -224.88M | -242.85% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 713.45M | 73.02% |
Kabuuang asset | 751.18M | 72.46% |
Kabuuang sagutin | 92.32M | 97.22% |
Kabuuang equity | 658.86M | — |
Natitirang share | 775.37M | — |
Presyo para makapag-book | 18.09 | — |
Return on assets | -111.03% | — |
Return on capital | -128.17% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -219.17M | -258.11% |
Cash mula sa mga operasyon | -101.94M | -109.43% |
Cash mula sa pag-invest | -485.16M | -681.15% |
Cash mula sa financing | 573.82M | 2,530.21% |
Net change in cash | -13.29M | -219.88% |
Malayang cash flow | -20.47M | 33.44% |
Tungkol
Itinatag
2003
Website
Mga Empleyado
265
